Plain-English translation of NCT05780450 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing transcranial direct current stimulation (tDCS)—a non-invasive technique that uses mild electrical currents to stimulate specific areas of the brain—to help reduce persistent headaches and chronic pain in people with long COVID. Researchers are comparing different ways of applying this brain stimulation to see which approach works best and whether it truly helps, compared to a sham (placebo) treatment.
Many people who recover from COVID-19 continue to experience debilitating headaches and body pain that don't respond well to standard treatments. This trial exists to find out whether this brain stimulation technique could offer relief for these lingering symptoms and improve quality of life.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive one of four types of brain stimulation treatment: standard brain stimulation, bifrontal stimulation, reverse-polarity stimulation, or placebo (sham) stimulation that feels similar but doesn't deliver active treatment. You will receive the same number of sessions with the same intensity and duration regardless of which group you're in. The study will measure how your headaches, pain, and sleep quality change over time.
AI-generated summary from trial data · Oct 23, 2026 · Not medical advice
Spain